GE HealthCare Technologies (GEHC)

Search documents
GEHC Stock May Gain Following the Launch of Sonic DL for 3D Imaging
ZACKS· 2024-12-02 17:25
GE HealthCare Technologies Inc. (GEHC) recently unveiled Sonic DL for 3D to further boost the company’s imaging portfolio. Sonic DL for 3D builds on GE HealthCare’s deep learning innovation legacy and the success of AIR Recon DL.By extending Sonic DL to 3D volumetric imaging, GE HealthCare is likely to expand its use beyond cardiac assessments to include brain, spine, orthopedic, and body exams. The goal of this expansion is to significantly cut scan times while maintaining the same remarkable 12 times scan ...
GEHC Stock Up Following New Tie-Up to Boost Cancer Research and Care
ZACKS· 2024-11-29 16:25
GE HealthCare Technologies Inc. (GEHC) announced its collaboration with Melbourne, Australia-based Peter MacCallum Cancer Centre on Monday. The tie-up will enable GEHC to further develop and explore the clinical and research possibilities of its total body positron emission tomography/computed tomography (PET/CT) technology designed with a 128 cm, ultra-high sensitivity detector. In turn, Peter MacCallum Cancer Center is expected to leverage the total body PET/CT technology designed by GE HealthCare for its ...
GEHC Stock May Gain Following the Launch of Pristina Via System
ZACKS· 2024-11-27 16:01
GE HealthCare Technologies Inc. (GEHC) recently unveiled the new Pristina Via mammography system. This system will provide mammography technologists with a suite of advanced tools that balance the demands of diagnostic accuracy and workflows to facilitate more patient-centered breast care.As GEHC continues to evolve its Senographe Pristina platform, Pristina Via brings advanced new features to help minimize repetitive tasks and streamline workflows so that mammography technologists can maintain their focus ...
GEHC Stock May Gain on Its Enhanced OEC 3D Mobile CBCT C-Arm Portfolio
ZACKS· 2024-11-25 15:45
GE HealthCare Technologies Inc. (GEHC) recently announced additional clinical applications of the OEC 3D mobile CBCT C-arm portfolio, which enable precise and efficient imaging during endoscopic bronchoscopy procedures in interventional pulmonology.For routine procedures like neuro-spine and orthopedic trauma, as well as interventional procedures like bronchoscopy, GE HealthCare's OEC 3D intraoperative mobile CBCT continues to show imaging superiority and versatility.Likely Trend of GEHC Stock Following the ...
FDA clears XENOVIEW® 3T Chest Coil in GE HealthCare MRI Systems
GlobeNewswire News Room· 2024-11-21 13:28
DURHAM, NC and LONDON, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical imaging technology leader in advanced Magnetic Resonance Imaging ("MRI") of the lungs, announces that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Company’s specialized MRI Chest Coil to now include GE HealthCare 3 Tesla (3T) MRI scanners for the visualization of Xenon-129 nuclei. With this new introduction, the Compa ...
GEHC Stock Likely to Gain on Portrait Mobile Solution's Prospects
ZACKS· 2024-11-21 12:36
GE HealthCare Technologies Inc. (GEHC) recently announced the publication of positive data from the two-phase COSMOS (Continuous Ward Monitoring with the GE HealthCare Portrait Mobile Monitoring Solution) pilot study conducted with Cleveland Clinic.The study demonstrated that real-time alerts from Portrait Mobile reduce the duration and severity of vital sign abnormalities. Continuous vital sign monitoring with Portrait Mobile enhances clinical decision-making, reduces alarm fatigue and improves patient out ...
GEHC Stock Falls Despite FDA Clearance for SIGNA MAGNUS MRI System
ZACKS· 2024-11-14 17:10
GE HealthCare Technologies (GEHC) recently announced the receipt of FDA clearance for its SIGNA MAGNUS, a 3.0T high-performance, head-only magnetic resonance imaging (MRI) scanner.This new innovative system has the potential to help detect neurological, oncological and psychiatric conditions by providing new clinical imaging and neuroscience capabilities. With SIGNA MAGNUS, GEHC is likely to provide neuroradiologists and neuroscience researchers with a tool that supports advanced imaging and biomarker resea ...
GE HealthCare: Light Up With Growth Indicators In Medical Tech, While Undervalued
Seeking Alpha· 2024-11-05 12:43
Core Insights - Albert Anthony is a Croatian-American media personality and financial contributor, reaching over 1 million investors globally since 2023 [1] - His content on Seeking Alpha averages over 25,000 views monthly, focusing on stock analysis and dividend income portfolio building [1] - In addition to financial analysis, he has engaged in city council politics in Croatia and ran for Parliament in 2024 [1] Company and Industry Summary - Albert Anthony provides curated analysis of stocks trading on major US exchanges, emphasizing a forward-looking perspective on stock performance [1] - He has experience in financial services, having worked at Charles Schwab and completed certifications from various prestigious institutions [1] - His involvement in the Croatian Economic Association indicates a commitment to economic discourse and policy development [1]
From Spin-Off To Standout: GE HealthCare Is Pretty Impressive
Seeking Alpha· 2024-10-30 19:07
Join iREIT on Alpha today to get the most in-depth research that includes REITs, mREITs, Preferreds, BDCs, MLPs, ETFs, and other income alternatives. 438 testimonials and most are 5 stars. Nothing to lose with our FREE 2-week trial . I love it when large conglomerates spin off major business segments. This is something I have discussed in a number of articles in the past. The main reason for this is the fact that we can diversify our own portfolios. Many decades Analyst's Disclosure: I/we have a beneficial ...
GE HealthCare Q3 Earnings Beat Estimates, Sales Meet, Net Margin Up
ZACKS· 2024-10-30 15:10
GE HealthCare (GEHC) reported third-quarter 2024 adjusted earnings per share (EPS) of $1.14, which beat the Zacks Consensus Estimate of $1.06 by 7.5%. Also, the bottom line improved 15.2% year over year. GAAP EPS in the quarter was $1.02, up 22.9% from the year-ago level. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar. Revenue Details The company reported revenues of $4.86 billion, up 1% year over year on a reported as well as organic basis. The top line was on par with the Zacks C ...